IL1B and uveitis: d-MAPPSTM contains soluble receptors of tumor necrosis factor alpha (sTNFRI, sTNFRII) and growth-related oncogene gamma (GRO-γ), which are able to prevent IL-1β-, TNF-α-, and IL-12-driven uveitis [11,16].